Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

June 06, 2017; 88 (23) Article

Effects of MCI subtype and reversion on progression to dementia in a community sample

Liesbeth Aerts, Megan Heffernan, Nicole A. Kochan, John D. Crawford, Brian Draper, Julian N. Trollor, Perminder S. Sachdev, Henry Brodaty
First published May 10, 2017, DOI: https://doi.org/10.1212/WNL.0000000000004015
Liesbeth Aerts
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan Heffernan
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole A. Kochan
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Crawford
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Draper
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian N. Trollor
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perminder S. Sachdev
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Brodaty
From the Dementia Collaborative Research Centre Network (L.A., M.H., H.B.), Centre for Healthy Brain Ageing (J.D.C., N.A.K., B.D., J.N.T., P.S.S., H.B.), and Department of Developmental Disability Neuropsychiatry (J.N.T.), School of Psychiatry, University of New South Wales; and Neuropsychiatric Institute (N.A.K., P.S.S.) and Academic Department for Old Age Psychiatry (B.D., H.B.), Prince of Wales Hospital, Randwick, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Effects of MCI subtype and reversion on progression to dementia in a community sample
Liesbeth Aerts, Megan Heffernan, Nicole A. Kochan, John D. Crawford, Brian Draper, Julian N. Trollor, Perminder S. Sachdev, Henry Brodaty
Neurology Jun 2017, 88 (23) 2225-2232; DOI: 10.1212/WNL.0000000000004015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
248

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective: We sought to understand the trajectory of mild cognitive impairment (MCI) better by examining longitudinally different MCI subtypes and progression to dementia and reversion to normal cognition in a community sample.

Methods: We evaluated the stability of MCI subtypes and risk of dementia over 4 biennial assessments as part of an ongoing prospective cohort study, the Sydney Memory and Ageing Study.

Results: While prevalence of MCI and different MCI subtypes remains relatively stable across all assessments, reversion from MCI and transitions between different MCI subtypes were common. Up to 46.5% of participants classified with MCI at baseline reverted at some point during follow-up. The majority (83.8%) of participants with incident dementia were diagnosed with MCI 2 years prior to their dementia diagnosis. Both reverters and participants with stable MCI were at an increased risk of progression to dementia compared to those without MCI at baseline (HR 6.4, p = 0.02, and HR 24.7, p < 0.001, respectively); however, the risk of dementia in participants with MCI who did not revert was higher than in reverters (HR 2.5, p = 0.01). This effect was specific to amnestic subtypes (MCI reverters vs nonreverters: amnestic MCI HR 3.3, p = 0.006; nonamnestic MCI: HR 1.3, p = 0.67).

Conclusion: Our findings indicate that the relevance of reversion for progression risk depends on the MCI subtype. Subtype specificity and longitudinal characterization are required for the reliable identification of individuals at high risk of developing dementia.

GLOSSARY

aMCI=
single-domain amnestic mild cognitive impairment;
amdMCI=
multiple-domain amnestic mild cognitive impairment;
CI=
confidence interval;
DSM-IV=
Diagnostic and Statistical Manual of Mental Disorders, 4th edition;
HR=
hazard ratio;
IADL=
instrumental activities of daily living;
MCI=
mild cognitive impairment;
MMSE=
Mini-Mental State Examination;
NM=
no mild cognitive impairment;
nMCI=
single-domain nonamnestic mild cognitive impairment;
nmdMCI=
multiple-domain nonamnestic mild cognitive impairment

Footnotes

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Supplemental data at Neurology.org

  • Received December 23, 2016.
  • Accepted in final form March 16, 2017.
  • © 2017 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • GLOSSARY
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • STUDY FUNDING
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Topics Discussed

  • All Cognitive Disorders/Dementia
  • Assessment of cognitive disorders/dementia
  • MCI (mild cognitive impairment)

Alert Me

  • Alert me when eletters are published
Neurology: 99 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise